Danish pharmaceutical large Novo Nordisk, maker of diabetes and weight-loss therapies Ozempic and Wegovy, which have gained recognition in recent times, mentioned Monday it was investing 8.5 billion kroner ($1.2 billion) to construct a brand new manufacturing unit in Denmark to supply medicine in opposition to uncommon illnesses.
The 40,000-square-metre (430,000-square-feet) manufacturing facility and warehouse in Odense “marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site,” the corporate mentioned in an announcement.
“Designed to be modular and flexible, it will accommodate multiple product types within rare diseases, such as hemophilia, both now and in the future,” Novo Nordisk mentioned.
Henrik Wulff, government vp at Novo Nordisk, mentioned the ability would assist the corporate “meet the growing global demand for our life-changing medicines.”
In November, the drugmaker posted a 21% rise in web revenue to 27.3 billion kroner ($3.85 billion) for the July-to-September interval, however lamented capability limitations at its manufacturing websites.
Novo Nordisk mentioned that building work on the Odense website had commenced and it’s scheduled to be accomplished in 2027.
It is anticipated to create 400 jobs as soon as accomplished.
Sales of Wegovy, which has been accepted to be used to deal with weight problems in Britain, Denmark, France, Germany, Norway and the United States, rose by 42% within the first 9 months of the 12 months, based on Novo Nordisk.
Sales of the corporate’s different semaglutide bestseller, Ozempic – an injectable anti-diabetic therapy that has turn into common for its slimming properties – soared by 54% in the identical interval.
Novo Nordisk has a maintain on 74% of the marketplace for weight-loss therapies.
The World Obesity Federation predicts that by 2035, over half of the world’s inhabitants can be chubby or overweight and the worldwide financial impression might then exceed $4 trillion a 12 months.
Source: www.dailysabah.com